henhaobio
Sign in

Journal of NeurochemistryBiochemistryPeer-reviewed journal article

Phosphoinositide- and Collybistin-Dependent Synaptic Clustering of Gephyrin

Nele BurdinaiD, Filip LiebschiD, Arthur MachaiD, Joaquín Lucas Ortuño Gil, Pia Frommelt, Irina RaisiD, Fabian BasleriD, Simon PoepseliD, Günter SchwarziD

PDFDOIPreprint
Citations
2
FWCI
0.78
Field percentile
top 31%

Abstract

Gephyrin is the main scaffolding protein at inhibitory synapses clustering glycine and GABA type A receptors. At specific GABAergic synapses, the nucleotide exchange factor collybistin recruits gephyrin to the postsynaptic membrane via interaction with phosphoinositides. However, the molecular mechanisms underlying the formation, maintenance and regulation of collybistin-dependent gephyrin clusters remain poorly understood. This study sheds light on the molecular mechanism of gephyrin cluster formation based on gephyrin self-oligomerization induced by collybistin, leading to the formation of a high-molecular weight (>5 MDa) gephyrin-collybistin complex, which is regulated in two ways: First, plasma-membrane phosphoinositides promote complex formation demonstrating their critical role in membrane targeting and stabilization of gephyrin-collybistin clusters at postsynaptic sites. Second, gephyrin phosphorylation at Ser325 abolishes complex formation with collybistin thus impairing collybistin-dependent gephyrin clustering at GABAergic synapses. Collectively, our data demonstrates a molecular mechanism for synaptic clustering of gephyrin which involves collybistin- and phosphoinositide-dependent formation of high-molecular gephyrin oligomers.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISImam '22Ortiz-López '26Chapdelaine '21Kostrz '25Yang '21Merlaud '26
79% semantic matchBiophysics
N. Imam, S. Choudhury, K. Hemmen+2 more·bioRxiv·May 30, 2022